Viewing Study NCT01351766


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-29 @ 12:17 AM
Study NCT ID: NCT01351766
Status: COMPLETED
Last Update Posted: 2022-05-18
First Post: 2011-05-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation
Sponsor: University of Maryland, College Park
Organization:

Study Overview

Official Title: Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation
Status: COMPLETED
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary purpose of this study is to develop a specialized behavioral activation treatment for smoking in youths ages 18-21 with elevated depressive symptoms. In the first phase we utilize focus groups and pilot testing with 15 youths to develop the behavioral activation smoking treatment for youth. In Phase II, we will conduct an open-label trial of the new treatment that will include 8 weeks of transdermal nicotine patch, which will begin at the time of quitting smoking. Participants will be followed over 26 weeks post-quit date. A subset of participants will also undergo an fMRI session to examine reward sensitivity.
Detailed Description: 1. 18-21 years of age,
2. a regular smoker for at least 6 months
3. currently smoking an average of at least 5 cigarettes per day
4. want to quit smoking
5. report current elevated depressive symptoms

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
R21DA029445 NIH None https://reporter.nih.gov/quic… View